Stocks › MEDP
Medpace Holdings, Inc.
MEDP·Nasdaq·
United States·USD
United States·USD$602.90
-17.61 (-2.84%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
MEDP
Medpace Holdings, Inc. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
MEDPS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of MEDP by members of U.S. Congress · 22 on record · 7 in the last 12 months
Whale Activity
Position changes in MEDP reported for 2026-09-30 by 1 tracked institutional filer
- Increased0
- New0
- Held0
- Decreased0
- Closed0
- No prior filing1
| Filer | Shares | Value | Change |
|---|---|---|---|
| ARGENT CAPITAL MANAGEMENT LLC | 57.0K | $35.6M | — |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by MEDP insiders, by quarter · Form 4
Recent Insider Transactions
731 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Troendle August J.President & CEO · Director | Sale | −22.0K | $625.47 | $13.7M | Sep 30, 2026 | Form 4 ↗ |
| Troendle August J.President & CEO · Director | Sale | −26.7K | $621.02 | $16.6M | Sep 29, 2026 | Form 4 ↗ |
| Troendle August J.President & CEO · Director | Sale | −2,410 | $620.07 | $1.5M | Sep 28, 2026 | Form 4 ↗ |
| Troendle August J.President & CEO · Director | Sale | −154 | $620.60 | $96K | Sep 25, 2026 | Form 4 ↗ |
| Troendle August J.President & CEO · Director | Sale | −27.8K | $621.33 | $17.3M | Sep 24, 2026 | Form 4 ↗ |
| Troendle August J.President & CEO · Director | Sale | −16.1K | $628.64 | $10.1M | Sep 23, 2026 | Form 4 ↗ |
| Troendle August J.President & CEO · Director | Sale | −49.0K | $628.11 | $30.8M | Sep 22, 2026 | Form 4 ↗ |
| Troendle August J.President & CEO · Director | Sale | −21.9K | $623.29 | $13.6M | Sep 21, 2026 | Form 4 ↗ |
| Troendle August J.President & CEO · Director | Sale | −10.9K | $620.40 | $6.7M | Sep 17, 2026 | Form 4 ↗ |
| Troendle August J.President & CEO · Director | Sale | −8,770 | $621.29 | $5.4M | Sep 16, 2026 | Form 4 ↗ |
| Troendle August J.President & CEO · Director | Sale | −16.0K | $620.84 | $9.9M | Sep 15, 2026 | Form 4 ↗ |
| Troendle August J.President & CEO · Director | Sale | −650 | $620.27 | $403K | Aug 27, 2026 | Form 4 ↗ |
| Kraft Robert O.Director · Director | Sale | −3,858 | $617.81 | $2.4M | Aug 26, 2026 | Form 4 ↗ |
| Troendle August J.President & CEO · Director | Sale | −4,000 | $620.03 | $2.5M | Aug 26, 2026 | Form 4 ↗ |
| Troendle August J.President & CEO · Director | Sale | −673 | $620.38 | $418K | Aug 25, 2026 | Form 4 ↗ |
| Troendle August J.President & CEO · Director | Sale | −1,983 | $620.23 | $1.2M | Aug 24, 2026 | Form 4 ↗ |
| Troendle August J.President & CEO · Director | Sale | −14.0K | $624.45 | $8.7M | Aug 21, 2026 | Form 4 ↗ |
| Brady Kevin M.CFO & Treasurer | Sale | −3,400 | $625.24 | $2.1M | Aug 20, 2026 | Form 4 ↗ |
| Troendle August J.President & CEO · Director | Sale | −27.2K | $618.79 | $16.8M | Aug 20, 2026 | Form 4 ↗ |
| Troendle August J.President & CEO · Director | Sale | −15.6K | $606.47 | $9.5M | Aug 19, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding MEDP · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF iShares Trust | 772.1K | $408.9M | 0.33% | Jun 30, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 724.9K | $383.9M | 0.02% | Jun 30, 2026 |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 523.7K | $277.3M | 0.15% | Jun 30, 2026 |
| T. Rowe Price Large-Cap Growth Fund T. Rowe Price Equity Funds, Inc. | 376.4K | $199.3M | 0.97% | Jun 30, 2026 |
| Invesco S&P MidCap Quality ETF Invesco Exchange-Traded Fund Trust | 295.8K | $170.7M | 3.13% | Jul 31, 2026 |
| VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS | 302.1K | $160.0M | 0.34% | Jun 30, 2026 |
| VANGUARD EXPLORER FUND | 269.6K | $155.6M | 0.70% | Jul 31, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 258.8K | $137.0M | 0.14% | Jun 30, 2026 |
| State Street SPDR S&P MidCap 400SM ETF Trust SPDR S&P MIDCAP 400 ETF TRUST | 173.6K | $91.9M | 0.33% | Jun 30, 2026 |
| FULLERTHALER BEHAVIORAL SMALL CAP EQUITY Capitol Series Trust | 173.0K | $91.6M | 0.72% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list MEDP's shares (CUSIP 58506Q109), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming Medpace Holdings, Inc. as client
No lobbying filings found naming Medpace Holdings, Inc. as the client.
Government Contracts
Federal awards to Medpace Holdings, Inc. · USAspending
No federal contract awards found for Medpace Holdings, Inc..
U.S. Patents
Recent USPTO applications naming Medpace Holdings, Inc.
No USPTO patent applications found for Medpace Holdings, Inc..
Annual Financials
From MEDP's 10-K filings · XBRL
No annual XBRL figures on record for MEDP. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No stock splits in MEDP's price history.
About Medpace Holdings, Inc.
From SEC EDGAR company records
Industry (SIC 8731)Services-Commercial Physical & Biological Research
SectorIndustrials
HeadquartersCINCINNATI, OH
IncorporatedDE
SEC CIK0001668397 ↗